Respiratory Care Devices Market Worth 24.07 Billion USD by 2021
PUNE, India, February 7, 2017 /PRNewswire/ --
According to a new market research report "Respiratory Care Devices Market by Product (Therapeutic (Ventilator, Mask, PAP Device, Inhaler, Nebulizer), Monitoring (Pulse Oximeter, Capnograph), Diagnostic, Consumables), End User (Hospital, Home Care), Indication - Global Forecast to 2021" published by MarketsandMarkets, The global respiratory care devices market is expected to reach USD 24.07 Billion by 2021 from USD 15.14 Billion in 2016, at a CAGR of 9.7% from 2016 to 2021.
(Logo: http://photos.prnewswire.com/prnh/20160303/792302 )
Browse 230 market data tables and 49 figures spread through 274 pages and in-depth TOC on "Respiratory Care Devices Market"
Early buyers will receive 10% customization on this report.
The major factors driving the growth of this market include high prevalence of respiratory diseases, rapid growth in the aging population, the high prevalence of smoking, rising urbanization and pollution levels, increasing incidence of preterm births, and lifestyle changes. The rapid developments in emerging markets such as Asia-Pacific and Latin America and the growing demand for point-of-care (POC) diagnostic devices are expected to provide significant growth opportunities for players operating in the respiratory care devices market in the coming years.
The rising demand for enhanced portable devices, growing demand for multimodal ventilators and focus of market players on expanding their geographic presence are the key trends of this market. However, the lacks of awareness of respiratory conditions leading to a large underdiagnosed and undertreated population and the harmful effects of certain respiratory care devices on neonates are the major challenges in this market.
Speak to our Expert @ http://www.marketsandmarkets.com/speaktoanalyst.asp?id=368
This market is segmented on the basis of type, disease/disorder, end user and regions. Based on type, the respiratory care devices market is segmented into therapeutic devices, monitoring devices, diagnostic devices, and consumables & accessories. The therapeutic devices segment is subsegmented into PAP devices, masks, ventilators, nebulizers, humidifiers, oxygen concentrators, inhalers, reusable resuscitators, nitric oxide delivery units, and oxygen hoods. The monitoring devices segment is subsegmented into pulse oximeters, capnographs and gas analyzers. The diagnostic devices segment is subsegmented into spirometers, polysomnography devices (PSG), peak flow meters and other diagnostic devices. The consumables and accessories segment is subsegmented into disposable masks, disposable resuscitators, tracheostomy tubes, nasal cannulas and other consumables and accessories. In 2015, therapeutic devices accounted for the largest share of the global respiratory care devices type market. The rising incidence of chronic diseases and growing geriatric population contributes to their largest share in respiratory care devices type market.
Based on disease/disorder, the respiratory care devices market is segmented into chronic obstructive pulmonary disease (COPD), sleep apnea, asthma, infectious diseases and other diseases/disorders. The other diseases/disorders segment includes lung cancer, pulmonary fibrosis, pulmonary embolism, cystic fibrosis, and allergies. In 2015, COPD accounted for the largest share of the global respiratory care devices market, by disease/disorder. The factors contributing to the growth of this technology segment includes increasing tobacco smoking prevalence and rising pollution levels globally.
Furthermore, on the basis of end users, the market is classified into hospitals, home care and ambulatory care. The hospitals companies segment accounted for the largest share in the global respiratory care devices market, by end users. The factors contributing to the growth of this end user segment includes the financial capabilities of hospitals to purchase high-priced instruments as well as the availability of trained professionals in hospitals to operate respiratory care devices.
Ask for PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=368
In 2015, North America accounted for the largest share of the global respiratory care devices market, followed by Europe, Asia-Pacific, and RoW. Growth in the developed markets in North America and Europe is mainly driven by the rising geriatric population, the presence of a well-established healthcare industry, availability of life sciences and medical research funding, rising geriatric population, growing demand for point-of-care diagnostic testing, and increasing government healthcare expenditure. As opposed to the North American and European markets, the demand in the APAC and Latin American markets is primarily driven by the growth in the overall healthcare industry. The rising geriatric population, growing per capita income, increasing investments in the healthcare industry by key market players, rising demand for cutting-edge technologies, low labor costs, favorable regulatory environment and expansion of private-sector hospitals to rural areas in various APAC and Latin American countries are some factors that will fuel the growth of respiratory care devices market in these regions.
Philips Healthcare (The Netherlands), ResMed, Inc. (U.S.), Medtronic plc (Ireland), Masimo Corporation (U.S.), and Fisher & Paykel Healthcare Corporation Limited (New Zealand) held the major share of the Respiratory Care Devices Market and will continue to dominate the market between 2016 and 2021. Other major players operating in this market are Becton, Dickinson and Company (U.S.), Chart Industries, Inc. (U.S.), Drägerwerk AG & Co. KGaA (Germany), and Hamilton Medical AG (Switzerland).
Browse Related Reports:
Respiratory Diagnostics Market by Product & Service (Instruments/Devices, Kits/Reagents), Test Type (Pulmonary Function Test, Imaging Test), Disease (TB, Lung Cancer, COPD), End User (Reference Laboratories, Physician Offices) - Global Forecast to 2021
Sleep Apnea Devices Market by Product, Diagnostic (PSG, Pulse Oximeter), Therapeutic [CPAP, APAP, BPAP, Masks (Full Face Mask), Oral Appliances (Mandibular Advancement Device)], End User (Home Care Settings, Hospitals) - Analysis & Global Forecasts to 2020
MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact: Mr. Rohan MarketsandMarkets 701 Pike Street Suite 2175, Seattle, WA 98101, United States 1-888-600-6441 Email: email@example.com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets